Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Baró

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The European Respiratory Journal|January 24, 2009
Validation of the COPD severity score for use in primary care: the NEREA studyM Miravitlles, C Llor, R de Castellar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 12, 2000
Alien hand sign after a right parietal infarctionJ Martí-Fàbregas, J Kulisevsky, E Baró, et al.
Therapeutic Drug Monitoring|August 15, 2000
Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassayI Sabaté, M Ginard, J M González, et al.
The British Journal of Dermatology|July 17, 1998
Bullous pemphigoid associated with acute glomerulonephritisM A Barnadas, C Gelpí, V Rocamora, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 30, 2004
[Impact of an intravenous mixture preparation device in hospital Pharmacy Departments. Perceived healthcare quality and user satisfaction]A Casado Collado, R Ibarz López, E Baró Ramos, et al.
Scandinavian Journal of Gastroenterology|November 1, 2001
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general populationF Mearin, X Badía, A Balboa, et al.
Journal of Investigational Allergology & Clinical Immunology|May 10, 2013
ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classificationsA Valero, I Izquierdo, J Sastre, et al.
Allergy|June 30, 2010
Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitisA Valero, M Ferrer, E Baró, et al.
Journal of Investigational Allergology & Clinical Immunology|October 30, 2009
Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version)A Valero, E Baró, J Sastre, et al.
Allergy|November 7, 2007
Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnairesA Valero, J Alonso, I Antépara, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The European Respiratory Journal|January 24, 2009
Validation of the COPD severity score for use in primary care: the NEREA studyM Miravitlles, C Llor, R de Castellar, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 12, 2000
Alien hand sign after a right parietal infarctionJ Martí-Fàbregas, J Kulisevsky, E Baró, et al.
Therapeutic Drug Monitoring|August 15, 2000
Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassayI Sabaté, M Ginard, J M González, et al.
The British Journal of Dermatology|July 17, 1998
Bullous pemphigoid associated with acute glomerulonephritisM A Barnadas, C Gelpí, V Rocamora, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 30, 2004
[Impact of an intravenous mixture preparation device in hospital Pharmacy Departments. Perceived healthcare quality and user satisfaction]A Casado Collado, R Ibarz López, E Baró Ramos, et al.
Scandinavian Journal of Gastroenterology|November 1, 2001
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general populationF Mearin, X Badía, A Balboa, et al.
Journal of Investigational Allergology & Clinical Immunology|May 10, 2013
ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classificationsA Valero, I Izquierdo, J Sastre, et al.
Allergy|June 30, 2010
Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitisA Valero, M Ferrer, E Baró, et al.
Journal of Investigational Allergology & Clinical Immunology|October 30, 2009
Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version)A Valero, E Baró, J Sastre, et al.
Allergy|November 7, 2007
Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnairesA Valero, J Alonso, I Antépara, et al.
Pageof 2